Japan's #3 Cancer Drug Grows on Trees. America Calls It a Weed! скачать в хорошем качестве

Japan's #3 Cancer Drug Grows on Trees. America Calls It a Weed!

Japan's #3 Cancer Drug Grows on Trees. America Calls It a Weed For over 2,000 years, traditional Chinese, Japanese, and Korean medicine used Phellinus linteus (meshima) for serious health conditions. In 1968, Japanese researchers discovered it showed 96.7% tumor growth inhibition in laboratory studies—higher than any other medicinal mushroom tested. Today, Asian hospitals use pharmaceutical-grade extracts alongside chemotherapy, while Western medicine largely ignores it. This video explores the documented history, verified scientific research, and economic reasons behind meshima's suppression in Western medicine. 00:00 Introduction – 96.7% Tumor Inhibition & the Mushroom America Ignores 01:35 Ancient China – Han Dynasty Records & the Mulberry Tree Rule 02:10 Korea's Royal Pharmacopeia – Sang Hwang in Three Kingdoms Medicine 02:37 Japan – Buddhist Monks & Temple Cultivation Since 552 CE 03:06 One Preparation Method Across Three Civilizations for 2,000 Years 03:55 How Western Medicine Erased 2,000 Years of Clinical Knowledge 04:38 1968 Japan – The Landmark Study That Beat Every Other Mushroom 05:57 The Research Decade – 1970s to 1990s Isolating the Key Compounds 06:46 Seoul National University 1996 – Immune Activation Without Toxicity 07:05 2003 Korea – Arthritis & Immune Modulation Confirmed 07:18 2004 Memorial Sloan Kettering – America Finally Pays Attention 08:07 Why Meshima Will Never Be Standard in American Oncology 09:31 The Supplement Industry Scandal – 67% of US Products Were Fake 10:50 Japan & Korea Never Stopped Using It – What Their Hospitals Do Today 11:33 Memorial Sloan Kettering Now Lists It – The Shift Is Happening 12:05 How to Choose a Quality Felinus Extract – What the Research Used 13:14 What Meshima Will NOT Do – Setting Honest Expectations 14:30 What the Research Suggests It May Support 15:02 Important Disclaimer – Consult Your Oncologist First 15:36 Conclusion – Molecules Don't Care About Profit Margins RESEARCH SOURCES: Ikekawa Study (1968): https://www.jstage.jst.go.jp/article/... Memorial Sloan Kettering Phellinus Information: https://www.mskcc.org/cancer-care/int... Phellinus as Alternative Cancer Therapy (PMC): https://pmc.ncbi.nlm.nih.gov/articles... Immune Stimulation Study (1996): https://pubmed.ncbi.nlm.nih.gov/8739191/ Arthritis Prevention Study (2003): https://pubmed.ncbi.nlm.nih.gov/12913... Current Medicinal Chemistry Review (2008): https://pubmed.ncbi.nlm.nih.gov/18537... Prostate Cancer Case Report (2004): https://pubmed.ncbi.nlm.nih.gov/15604... Hepatocellular Carcinoma Regression (2005): https://pubmed.ncbi.nlm.nih.gov/15740... Bioactive Components Review (2019): https://www.mdpi.com/1420-3049/24/10/... Polysaccharides Structure-Activity (2023): https://pubmed.ncbi.nlm.nih.gov/38072... DISCLAIMER: This content is for educational purposes only and does not constitute medical advice. Phellinus linteus is not FDA-approved to diagnose, treat, cure, or prevent any disease. Always consult qualified healthcare professionals before using any supplement, especially during cancer treatment. #PhellinsLinteus #Meshima #MedicinalMushrooms #CancerResearch #TraditionalMedicine #NaturalHealth #HealthDocumentary #Immunology #AsianMedicin6